放疗后乳房重建:基于全国理赔数据的术后并发症评估
结果显示假体重建并发症率45.3%、失败率29.4%,自体组织分别为30.8%和4.3%。多变量回归中假体重建的并发症风险约为自体组织的2倍,失败风险约为11倍。
要点
- 放疗患者假体重建并发症率45.3%,失败率29.4%。
- 放疗患者自体组织重建并发症率30.8%,失败率4.3%。
- 假体重建较自体组织的并发症风险约2倍、失败风险约11倍。
核心结论
- 放疗患者假体乳房重建虽流行但并发症和失败率显著,短期失败率接近30%。
- 需充分告知患者潜在并发症风险,谨慎共同决策。
研究设计与样本
- 记录人口学和临床治疗数据(含放疗与重建的时间关系),以及假体和自体组织重建后的并发症与失败。
- 采用多变量逻辑回归,以术后并发症为因变量,人口学和临床变量为自变量。
主要发现
- 假体重建总体并发症率为45.3%,自体组织重建为30.8%。
- 假体重建失败率为29.4%,自体组织重建为4.3%。
- 多变量逻辑回归中,假体重建患者发生任何并发症的比值比为自体组织的2倍,失败比值比为11倍。
关键数值与推荐
- 假体重建并发症率45.3%,失败率29.4%;自体组织重建并发症率30.8%,失败率4.3%。
- 假体重建较自体组织的并发症比值比约2倍,失败比值比约11倍。
- 证据等级:治疗性研究,III级。
临床怎么用
- 对放疗后乳房重建患者,应充分披露假体重建的高并发症和失败风险。
- 与患者进行共同决策,权衡假体与自体组织重建的利弊。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implant-based reconstruction rates have risen among irradiation-treated breast cancer patients in the United States. This study aims to assess the morbidity associated with various breast reconstruction techniques in irradiated patients. METHODS: From the MarketScan Commercial Claims and Encounters database, the authors selected breast cancer patients who had undergone mastectomy, irradiation, and breast reconstruction from 2009 to 2012. Demographic and clinical treatment data, including data on the timing of irradiation relative to breast reconstruction were recorded. Complications and failures after implant and autologous reconstruction were also recorded. A multivariable logistic regression model was developed with postoperative complications as the dependent variable and patient demographic and clinical variables as independent variables. RESULTS: Four thousand seven hundred eighty-one irradiated patients who met the inclusion criteria were selected. A majority of the patients [n = 3846 (80 percent)] underwent reconstruction with implants. Overall complication rates were 45.3 percent and 30.8 percent for patients with implant and autologous reconstruction, respectively. Failure of reconstruction occurred in 29.4 percent of patients with implant reconstruction compared with 4.3 percent of patients with autologous reconstruction. In multivariable logistic regression, irradiated patients with implant reconstruction had two times the odds of having any complication and 11 times the odds of failure relative to patients with autologous reconstruction. CONCLUSIONS: Implant-based breast reconstruction in the irradiated patient, although popular, is associated with significant morbidity. Failures of reconstruction with implants in these patients approach 30 percent in the short term, suggesting a need for careful shared decision-making, with full disclosure of the potential morbidity. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Chetta MD, Aliu O, Zhong L, et al. Reconstruction of the Irradiated Breast: A National Claims-Based Assessment of Postoperative Morbidity. Plast Reconstr Surg. 2017. PMID: 28002254. doi:10.1097/PRS.0000000000003168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。